Advertisement

Topics

Baggerman Company Profile

01:02 EST 25th November 2017 | BioPortfolio

Investigational medicinal products (IMP’s) are on the agenda these months as we are to take care of the regulatory details of two such products. For an ophthalmological product we are co-writing parts of the Investigational Medicinal Product Dossier (IMPD). A second project includes a new radiopharmaceutical compound for which we have to comment on the supply chain. In addition we will support the manufacturing company with the application for a pharmaceutical manufacturing license. As you may know, IMP’s are subject to GMP-regulations as much as regular medicinal products, requiring such a license as well as the appointment of a Qualified Person to release the batches.


Speaking of supply chains, the use of direct-to-patient (DtP) distribution of medicinal products has grown steadily over the years. This type if distribution delivers medicinal products from a wholesaler directly to patients at home without the interference of their community pharmacy. Especially cold-chain biotechnological products are under consideration for this type of distribution and a number of wholesalers are now offering this service to pharmaceutical companies. One of these companies has asked to profile these suppliers, enabling them to set up such a DtP-service for one of their products.



A third project requiring much attention this quarter, refers to the transfer of the production of a Type II medical device from one company to another company abroad. Moreover, it is not just a simple transfer, but some design changes are incorporated in the transfer project. This requires adaptation and extension of the Technical File to reflect these new manufacturing details as well as the new design. And, last but not least, this all needs the final blessing of the Notified Body for which purpose audits have been scheduled in late June, early July. We expect to finalize this project prior to the European Summer Holiday in August.

Location

Bleyslaan 40
Eindhoven
GN 5622
Netherlands

Contact

Phone: (040)- 2453611
Fax: (040)- 2438514
Email: info@bfc.nl


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Baggerman

Investigational medicinal products (IMP’s) are on the agenda these months as we are to take care of the regulatory details of two such products. For an ophthalmological product we are co-writing par...

More Information about "Baggerman" on BioPortfolio

We have published hundreds of Baggerman news stories on BioPortfolio along with dozens of Baggerman Clinical Trials and PubMed Articles about Baggerman for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Baggerman Companies in our database. You can also find out about relevant Baggerman Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record